Does animal-free casein actually behave like the real thing?
Formulation tests comparing Opalia BC-1 casein against conventional bovine casein in three food applications.
Technical writing from the Opalia team on cell culture, AI-driven bioprocess optimization, and what animal-free dairy proteins mean for food manufacturers.
Formulation tests comparing Opalia BC-1 casein against conventional bovine casein in three food applications.
A frank look at the functional requirements that plant proteins have not met, and where cell-culture approaches are positioned.
Regulatory landscape for novel dairy-equivalent ingredient labeling in Canada and major export markets.
The process challenges that emerged as we moved from research-scale flasks to our current pilot bioreactor.
After dozens of formulation conversations, these are the technical and commercial questions that come up every time.
A summary of the technical decisions, failures, and improvements from Opalia's first 12 production pilot batches.
How we built the optimization feedback loop that improved protein purity across our first batch series.
The structural complexity of native casein micelles and why single-protein fermentation approaches face fundamental limits.
A technical comparison of the two leading approaches to animal-free dairy protein production, and the reasoning behind our platform choice.
How the two main production platforms differ in output, cost trajectory, and functional protein quality.
Why Quebec's research infrastructure and university ecosystem are drawing cell-ag startups to the city.
What we are building, why we started in Montreal, and how cell culture gives dairy proteins a new supply chain.